{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T21:03:14Z","timestamp":1773954194060,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,8,5]],"date-time":"2017-08-05T00:00:00Z","timestamp":1501891200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s10072-017-3083-6","type":"journal-article","created":{"date-parts":[[2017,8,5]],"date-time":"2017-08-05T03:19:57Z","timestamp":1501903197000},"page":"1927-1931","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Validity, reliability, and sensitivity to change of the myasthenia gravis activities of daily living profile in a sample of Italian myasthenic patients"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7433-7779","authenticated-orcid":false,"given":"Alberto","family":"Raggi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Antozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulvio","family":"Baggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilde","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renato","family":"Mantegazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,5]]},"reference":[{"key":"3083_CR1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1196\/annals.1254.054","volume":"998","author":"R Mantegazza","year":"2003","unstructured":"Mantegazza R, Baggi F, Antozzi C, Confalonieri P, Morandi L, Bernasconi P, Andreetta F, Simoncini O, Campanella A, Beghi E, Cornelio F (2003) Myasthenia gravis (MG): epidemiological data and prognostic factors. Ann N Y Acad Sci 998:413\u2013423","journal-title":"Ann N Y Acad Sci"},{"key":"3083_CR2","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","volume":"357","author":"A Vincent","year":"2001","unstructured":"Vincent A, Palace J, Hilton-Jones D (2001) Myasthenia gravis. Lancet 357:2122\u20132128","journal-title":"Lancet"},{"key":"3083_CR3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/mus.21713","volume":"42","author":"TM Burns","year":"2010","unstructured":"Burns TM (2010) History of outcome measures for myasthenia gravis. Muscle Nerve 42:5\u201313","journal-title":"Muscle Nerve"},{"key":"3083_CR4","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3109\/09638288.2013.804591","volume":"36","author":"A Raggi","year":"2014","unstructured":"Raggi A, Schiavolin S, Leonardi M, Antozzi C, Baggi F, Maggi L, Mantegazza R (2014) Development of the MG-DIS: an ICF-based disability assessment instrument for myasthenia gravis. Disabil Rehabil 36:546\u2013555","journal-title":"Disabil Rehabil"},{"key":"3083_CR5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1749-6632.2012.06817.x","volume":"1274","author":"S Muppidi","year":"2012","unstructured":"Muppidi S (2012) The myasthenia gravis\u2014specific activities of daily living profile. Ann N Y Acad Sci 1274:114\u2013119","journal-title":"Ann N Y Acad Sci"},{"key":"3083_CR6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/mus.22140","volume":"44","author":"S Muppidi","year":"2011","unstructured":"Muppidi S, Wolfe GI, Conaway M, Burns TM, MG composite and MG-QOL15 study group (2011) MG-ADL: still a relevant outcome measure. Muscle Nerve 44:727\u2013731","journal-title":"Muscle Nerve"},{"key":"3083_CR7","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s10072-016-2556-3","volume":"37","author":"D Cioncoloni","year":"2016","unstructured":"Cioncoloni D, Casali S, Ginanneschi F, Carone M, Veronica B, Rossi A, Giannini F (2016) Major motor-functional determinants associated with poor self-reported health-related quality of life in myasthenia gravis patients. Neurol Sci 37:717\u2013723","journal-title":"Neurol Sci"},{"key":"3083_CR8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","volume":"375","author":"GI Wolfe","year":"2016","unstructured":"Wolfe GI, Kaminski HJ, Aban IB et al (2016) Randomized trial of thymectomy in myasthenia gravis. N Engl J Med 375:511\u2013522","journal-title":"N Engl J Med"},{"key":"3083_CR9","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/01.wnl.0000312374.95186.cc","volume":"71","author":"DB Sanders","year":"2008","unstructured":"Sanders DB, Hart IK, Mantegazza R, Shukla SS, Siddiqi ZA, De Baets MH, Melms A, Nicolle MW, Solomons N, Richman DP (2008) An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis. Neurology 71:400\u2013406","journal-title":"Neurology"},{"key":"3083_CR10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/mus.24911","volume":"53","author":"C Antozzi","year":"2016","unstructured":"Antozzi C, Brenna G, Baggi F, Camera G, Maggi L, Rezzani C, Montomoli C, Mantegazza R (2016) Validation of the Besta Neurological Institute rating scale for myasthenia gravis. Muscle Nerve 53:32\u201337","journal-title":"Muscle Nerve"},{"key":"3083_CR11","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.0b013e3181dc1b1e","volume":"74","author":"TM Burns","year":"2010","unstructured":"Burns TM, Conaway M, Sanders DB, MG Composite and MG-QOL15 Study Group (2010) The MG composite: a valid and reliable tool for myasthenia gravis. Neurology 74:1434\u20131440","journal-title":"Neurology"},{"key":"3083_CR12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1477-7525-8-51","volume":"8","author":"O Garin","year":"2010","unstructured":"Garin O, Ayuso-Mateos JL, Almansa J, Nieto M, Chatterji S, Vilagut G, Alonso J, Cieza A, Svestkova O, Burger H, Racca V, Francescutti C, Vieta E, Kostanjsek N, Raggi A, Leonardi M, Ferrer M, MHADIE consortium (2010) Validation of the \u201cWorld Health Organization Disability Assessment Schedule, WHODAS-2\u201d in patients with chronic diseases. Health Qual Life Outcomes 8:51","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"3083_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/09638288.2016.1223177","volume":"11","author":"S Federici","year":"2016","unstructured":"Federici S, Bracalenti M, Meloni F, Luciano JV (2016) World Health Organization disability assessment schedule 2.0: an international systematic review. Disabil Rehabil 11(1):167. doi:\n10.1080\/09638288.2016.1223177","journal-title":"Disabil Rehabil"},{"key":"3083_CR14","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00415-016-8072-9","volume":"263","author":"A Raggi","year":"2016","unstructured":"Raggi A, Leonardi M, Schiavolin S, Antozzi C, Brenna G, Maggi L, Mantegazza R (2016) Validation of the MG-DIS: a disability assessment for myasthenia gravis. J Neurol 263:871\u2013882","journal-title":"J Neurol"},{"key":"3083_CR15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","volume":"55","author":"A Jaretzki 3rd","year":"2000","unstructured":"Jaretzki A 3rd, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, Sanders DB (2000) Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 55:16\u201323","journal-title":"Neurology"},{"key":"3083_CR16","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/mus.21185","volume":"38","author":"TM Burns","year":"2008","unstructured":"Burns TM, Conaway MR, Cutter GR, Sanders DB, Muscle Study Group (2008) Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite. Muscle Nerve 38:1553\u20131562","journal-title":"Muscle Nerve"},{"key":"3083_CR17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.nmd.2016.11.009","volume":"27","author":"AF Lipka","year":"2014","unstructured":"Lipka AF, Vrinten C, van Zwet EW, Schimmel KJM, Cornel MC, Kuijpers MR, Hekster YA, Weinreich SS, Verschuuren JJGM (2014) Ephedrine treatment for autoimmune myasthenia gravis. Neuromuscul Disord 27:259\u2013265","journal-title":"Neuromuscul Disord"},{"key":"3083_CR18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.intimp.2010.12.012","volume":"11","author":"CB Zhao","year":"2011","unstructured":"Zhao CB, Zhang X, Zhang H, Hu XQ, Lu JH, Lu CZ, Xiao BG (2011) Clinical efficacy and immunological impact of tacrolimus in Chinese patients with generalized myasthenia gravis. Int Immunopharmacol 11:519\u2013524","journal-title":"Int Immunopharmacol"},{"key":"3083_CR19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10072-016-2769-5","volume":"38","author":"X Tao","year":"2017","unstructured":"Tao X, Wang W, Jing F, Wang Z, Chen Y, Wei D, Huang X (2017) Long-term efficacy and side effects of low-dose tacrolimus for the treatment of myasthenia gravis. Neurol Sci 38:325\u2013330","journal-title":"Neurol Sci"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-017-3083-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-3083-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-017-3083-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T02:01:25Z","timestamp":1508119285000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-017-3083-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,5]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["3083"],"URL":"https:\/\/doi.org\/10.1007\/s10072-017-3083-6","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,5]]}}}